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Myelination in the Absence of Galactocerebroside
and Sulfatide: Normal Structure with Abnormal
Function and Regional Instability
Timothy Coetzee,1,7 Nobuya Fujita,1,7 Jeffrey Dupree,1 nature of this specialized membrane is of practical im-
portance.Riyi Shi,3 Andrew Blight,3 Kinuko Suzuki,1,2
Biochemically, myelin exhibits a unique compositionKunihiko Suzuki,1,4,6 and Brian Popko,1,5,6
with >70% of the dry weight consisting of lipids and the1UNC Neuroscience Center
remainder being comprised of a relatively simple array of2Department of Pathology and Laboratory Medicine
myelin-specific proteins (Morell et al., 1994). Significant3Department of Surgery
insights into the structural and functional properties ofDivision of Neurosurgery
the sheath have been gained from studies of naturally4Department of Neurology and Psychiatry
occurring and experimentally induced rat and mouse5Department of Biochemistry and Biophysics
mutants defective in these proteins (Campagnoni and6Program in Molecular Biology and Biotechnology
Macklin, 1988; Giese et al., 1992; Boison and Stoffel,University of North Carolina at Chapel Hill
1994; Li et al., 1994; Montag et al., 1994; Adlkofer et al.,Chapel Hill, North Carolina 27599
1995; Lunn et al., 1995). With the exception of mice
lacking myelin-associated glycoprotein (MAG) (Li et al.,
1994; Montag et al., 1994), analysis of these mutants has
Summary shown that elimination of the structural myelin proteins
disrupts the myelination process and, as a conse-
The vertebrate nervous system is characterized by quence, disrupts the proper function of the nervous sys-
ensheathment of axons with myelin, a multilamellar tem. In the case of MAG, mice lacking this quantitatively
membrane greatly enriched in the galactolipid ga- minor myelin component form functional myelin that
lactocerebroside (GalC) and its sulfated derivative exhibits only subtle morphological abnormalities.
sulfatide. We have generated mice lacking the en- In contrast to the myelin proteins, relatively little is
zyme UDP-galactose:ceramide galactosyltransferase known about the functional importance of myelin lipids.
(CGT), which is required for GalC synthesis. CGT-defi- Among the most abundant myelin lipids are galactocere-
broside (GalC) and its sulfated derivative, sulfatide,cient mice do not synthesize GalC or sulfatide but
which together constitute z27% of the myelin lipid (Nor-surprisingly form myelin containing glucocerebroside,
ton and Cammer, 1984). This abundance has led to thea lipid not previously identified in myelin. Microscopic
suggestion that GalC and sulfatide have an importantand morphometric analyses revealed myelin of normal
role in the structure of myelin (Curalto, 1987). In addition,ultrastructural appearance, except for slightly thinner
a number of studies have suggested that GalC may havesheaths in the ventral region of the spinal cord. Never-
a function in the development of oligodendrocytes. GalCtheless, these mice exhibit severe generalized trem-
is one of the earliest markers denoting differentiation oforing and mild ataxia, and electrophysiological ana-
oligodendrocytes from the O2A precursor to an imma-lysis showed conduction deficits consistent with
ture oligodendrocyte (Pfeiffer et al., 1993), and anti-GalCreduced insulative capacity of the myelin sheath.
antibodies reversibly inhibit differentiation of immatureMoreover, with age, CGT-deficient mice develop pro-
oligodendrocytes into mature oligodendrocytes (Bansalgressive hindlimb paralysis and extensive vacuolation
and Pfeiffer, 1989). These observations suggest thatof the ventral region of the spinal cord. These results
GalC may be transducing signals essential to maturationindicate that GalC and sulfatide play important roles
of oligodendrocytes. This possibility is furthersupportedin myelin function and stability.
by studies demonstrating that anti-GalC antibodies in-
duce calcium flux across oligodendrocyte membranes
Introduction and subsequent rearrangement of microtubules (Dyer
and Benjamins, 1988, 1989, 1990, 1991). Additional stud-
The myelin sheath is a multilamellar, spirally wrapping ies have shown that anti-GalC antibodies inhibit myelin-
extension of the plasma membranes of oligodendro- ation in vitro and in vivo (Fry et al., 1974; Dorfman et
cytes in the central nervous system (CNS) and of al., 1979; Ranscht et al., 1987; Rosenbluth et al., 1994).
Schwann cells in the peripheral nervous system (PNS) Together, these studies raise the intriguing possibility
(reviewed in Morell et al., 1994). This specialized struc- that GalC functions in processes essential to oligoden-
ture exhibits a low capacitance and as a result serves drocyte developmentand subsequent myelination (Ben-
as an axonal insulator that facilitates transmission of jamins and Dyer, 1990; Dyer, 1993).
GalC is synthesized by addition of galactose to cera-nerve impulses by saltatory conduction. The end result
mide in a single step with UDP-galactose as the donoris a reduction in theenergy and space utilization require-
(Morell and Radin, 1969). The enzyme responsible forments of the nerve cell. Since several human disease
this reaction is UDP-galactose:ceramide galactosyl-states such as multiple sclerosis,Pelizeaus–Merzbacher
transferase (CGT) (E. C. 2.4.2.62), a glycosylated micro-disease, Charcot–Marie–Tooth disease, metachromatic
somal enzyme consisting of 541 amino acids with aleukodystrophy, and globoid leukodystrophy result from
molecular weight of z61 kDa (Morell and Radin, 1969;deficiency or disruption of myelin, understanding the
Neskovic et al., 1986; Schulte and Stoffel, 1993; Stahl
et al., 1994; Schaeren-Wiemers et al., 1995). Previously,
we and others reported the isolation and characteriza-7 The first two authors contributed equally to this work and are listed
alphabetically. tion of rat cDNA clones encoding CGT (Schulte and
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Stoffel, 1993; Stahl et al., 1994; Schaeren-Wiemers et
al., 1995). These studies showed that CGT is abundantly
expressed in the actively myelinating CNS and PNS,
consistent with its role in myelination. Subsequently, we
have isolated and characterized genomic clones con-
taining the mouse Cgt gene, which is composed of six
exons located on chromosome 3 (Coetzee et al., 1996).
Given the number of functions attributed to GalC, we
have attempted to ascertain the effect of elimination of
this lipid on the development and function of the nervous
system. We have found that CGT-deficient mice cannot
synthesize GalC or sulfatide and yet are able to form
compact myelin. This report describes the conse-
quences of the lack of CGT on the clinical, pathological,
biochemical, and electrophysiological phenotype of
these animals.
Results
Disruption of the Mouse Cgt Gene
The targeting vector (pPNTCGT) was generated by in-
serting the neomycin resistance gene (neo) into a KpnI
site present within exon 2, 219 nt downstream of the
initiation codon of the Cgt gene (Figure 1A) (Coetzee et
al., 1996). NotI-linearized pPNTCGT was electroporated
into BK4 ES cells, a subclone of line E14TG2a, and
neomycin resistant clones selected using G418. Follow-
Figure 1. Targeted Disruption of the Mouse Cgt Locusing selection, 52 ES clones were isolated of which 14
(A) A partial restriction map of the Cgt gene, targeting construct,carried the targeted recombination event as determined
and the expected replacement event are shown. The neomycin re-using a probe outside the targeting construct (Probe A,
sistance gene (neo) was inserted into a KpnI (K) site located withinFigure 1A; data not shown).
exon 2, which contains the initiation codon and codes for the
Targeted ES cells were injected into C57Bl/6J blasto- N-terminal half of the CGT enzyme. The relative locations of the
cysts and 16 chimeric animals generated. Five males screening probes (Probes A and B) are shown. The top double-
and one female transmitted the targeted allele to germ- headed arrow indicates the endogenous 15 kb BamHI fragment,
detected by both probes, that is characteristic of the wild-type gene.line cells. Heterozygote F1 animals were interbred to
The addition of the neo gene introduces a new BamHI site withingenerate homozygote Cgt-deficient mice. The genotype
the targeted allele. This site yields a diagnostic 8 kb BamHI fragmentwas determined using an internal Cgt-specific probe
that is detected by both probes. Probe B also detects a 9 kb BamHI
(Probe B, Figure 1A). Probe B detected a 15 kb BamHI fragment corresponding to sequences downstream of the neo gene.
fragment in both wild type and heterozygotes but not (B) Southern blot analysis of tail DNA from wild type (1/1), heterozy-
homozygotes (Figure 1B). In addition, 8 and 9 kb frag- gous (1/2), and homozygous (2/2) are shown. Tail DNA was di-
gested with BamHI, and hybridized with probe B.ments were detected in both heterozygotes and the
(C) Northern blot analysis of total RNA was isolated from brains ofhomozygotes, but not in wild type (Figure 1B). These
Cgt 1/1, 1/2, and 2/2 mice is shown. Total RNA separated byresults are consistent with the predicted insertion of a
formaldehyde-agarose (0.8%) gel electrophoresis, transferred to ny-
unique BamHI site into the second exon of the targeted lon membranes, and probed for the expression of CGT, neomycin
Cgt gene. Finally, Northern blot analysis of brain RNA (NEO), myelin basic protein (MBP), proteolipid protein (PLP), and
indicated that expression of full-length CGT mRNA was myelin-associated glycoprotein (MAG). All five RNA sets were run
on the same gel in parallel and were loaded from master mixes ofabolished in the homozygote, and that a neomycin-con-
1/1, 1/2, and 2/2 RNA. All five membranes were analyzed fortaining truncated transcript was expressed in both het-
18S RNA and showed similar results.erozygote and homozygote animals (Figure 1C). Dis-
tribution of the 2/2 animals followed Mendelian
segregation indicating that the 2/2 genotype was not hindlimbs with clenching of the paws, dragging of the
embryonic lethal. hindquarters, and vertical positioning of the tail. In addi-
tion, many animals clasped the hindlimbs to the body
when held by the tail and showed a tendency to haveClinical Phenotype of Cgt2/2 Mice
Heterozygotes have not exhibited a clinical phenotype closed eyes. No seizures were observed. Generally, 2/2
animals were smaller than littermates with body weightthroughout the first nine months of observation. No clini-
cal phenotype was detectable in 2/2 mice until postna- of one-half to two-thirds that of 1/1 and 1/2 lit-
termates. With age, 2/2 animals exhibited a progressivetal day (PND) 12–14, at which time Cgt2/2 animals exhib-
ited a gross jerking of the head and mildly ataxic loss of function in the hindlimbs, such that by PND60
many animals had lost much of their ability to move, laylocomotion. Between PND 16 and 20, tremoring became
noticeable at rest and very pronounced during move- on their sides or back, and showed signs of labored
breathing. Age at death of 2/2 mice was variable withment. Locomotion was characterized by splaying of the
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Cgt2/2 Mice Form Compact Myelin
Although Northern blot analysis showed that CGT mRNA
was absent from the homozygous animals, expression
of mRNAs for myelin basic protein (MBP), proteolipid
protein (PLP), and myelin-associated glycoprotein
(MAG) was not significantly diminished in the 2/2 ani-
mals compared with the 1/2 and 1/1 animals (Figure
1C). Consistent with the Northern blot analysis, immuno-
cytochemical analysis of PND 24 cerebellum and spinal
cord tissue sections showed extensive expression of
MBP (data not shown). Electron microscopy of the optic
nerve of PND 24 animals showed that myelin was indeed
formed in 2/2 animals (Figure 3B). Myelin in 2/2 ani-
mals exhibited the characteristic ultrastructure of com-
pact myelin, including the major dense line and intrape-
riod line (Figure 3D). Similar results were seen with dorsal
and ventral columns of spinal white matter (data not
shown), and no difference was observed between 1/1
and 2/2 PND 43 sciatic nerve (Figure 3F).
To quantitate the extent of myelination in the PND 24
Figure 2. Analysis of Total Brain Lipids from Cgt2/2 Mice mutant animals, morphometric analysis was performed
(A) Total brain lipids were extracted from brain of 16 and 24 day old on nerve fibers from optic nerve, sciatic nerve, and the
Cgt 1/1, 1/2, and 2/2 mice, mercuric chloride-treated, saponified, dorsal and ventral columns of the spinal white matter
and separated on HPTLC 60 plates at 3 mg–wet weight equivalent
(Table 1). The majority of axons in all fields of 2/2 ani-per sample. The solvent system was chloroform-methanol-water
mals analyzed were myelinated. No difference was nota-(70:30:4, v/v/v). Lipids were visualized with copper acetate spray
and heating. ble between mutant and control animals in the extent
(B) Lipids were prepared as in (A) and separated by TLC on borate of myelination in fibers derived from the optic and sciatic
impregnated plates. The solvent system was chloroform-methanol- nerves. A subtle reduction in myelin thickness was nota-
concentrated ammonia (70:30:5, v/v/v).
ble in the dorsal column of spinal white matter. In theAbbreviations: NFA, normal fatty acid; HFA, a-hydroxy-fatty acid;
ventral white matter, the mean myelin thickness wasglc-cer, glucocerebroside; SPM, sphingomyelin.
reduced by z30%, and the ratio of axon diameter to fiber
diameter (g) slightly increased in 2/2 animals compared
with 1/1 animals.
some animals dying around PND 18–30 and others sur-
viving past PND 90. Female 2/2 animals are fertile but
HFA-GlcC Is Present in Myelinappear incapable of caring for their pups.
Consistent with the histological and ultrastructural evi-
dence, myelin was isolated at nearly 50% of the normalGalC Is Absent from Brain Lipids
yield from two pooled PND 24 and 26 2/2 brains (1/1,Thin-layer chromatography (TLC) of the saponified total
9.5 mg/g; 2/2, 4.5 mg/g). The altered myelin lipid com-brain lipid fraction clearly showed that both normal fatty
position likely contributed to the reduced myelin yieldacid– (NFA-) and hydroxy-fatty acid– (HFA-) -containing
from the mutant animals. Ultrastructural analysis of bothGalC and sulfatide were absent from the brain of the
1/1 and 2/2 preparations showed myelin lamellae with
2/2 mouse (Figure 2A). GalC and sulfatide levels were
major dense lines and intraperiod lines (data not shown).reduced in 1/2 animals compared with normal. In par-
Furthermore, TLC analysis of the lipids present in theticular, the levels of NFA-GalC and NFA-sulfatide were
myelin preparation showed a pattern very similar to thatreduced in 16-day-old 1/2 animals compared with 1/1
of the whole brain tissue (Figure 4). As expected, nocontrol. No differences were seen in the levels of choles-
GalC or sulfatide could be detected in the 2/2 myelin.terol, glycerophospholipids, and gangliosides (data not
HFA-GlcC was present in myelin at a similar proportionshown).
as NFA-GalC in the wild-type myelin. Finally, the myelinInterestingly, a conspicuous band displaying a mobil-
fraction isolated from 2/2 brains contained a muchity between NFA- and HFA-GalC was present only in
greater amount of HFA-sphingomyelin than normal NFA-the 2/2 fraction (Figure 2A). This mobility pattern was
sphingomyelin (Figure 4).consistent with HFA-glucocerebroside (GlcC). The as-
signment of HFA-GlcC was supported by TLC on borate-
impregnated plates. Under these conditions GalC ex- Nerve Conduction Is Disrupted in Cgt2/2 Mice
Since the clinical phenotype was suggestive of a disrup-hibits a retarded mobility, whereas GlcC mobility is
unaffected (Figure 2B). Additionally, a band was seen tion of nerve conduction, we measured action potential
conduction in the spinal cord of PND 24–28 mice andbelow the sphingomyelin band in the saponified 2/2
preparation on borate-impregnated plates (Figure 2B). found that amplitude of the compound action potential
in 2/2 spinal cord was smaller and exhibited a longerThe slower mobility suggested that this band corre-
sponds to HFA-sphingomyelin. Visualization by both latency than that in 1/1 control (Figure 5B; Table 2). In
addition, the compound action potential in 2/2 spinalacid molybdate and anisaldehyde sprays gave blue col-
ors expected for sphingomyelin. cord was composed of distinct subcomponents, and
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Figure 3. Ultrastructural Analysis of Myelination in Optic and Sciatic Nerves
(A–D) Electron microscopy of PND 24 optic nerve are shown. (A) and (C), 1/1; (B) and (D), 2/2 . Bars: (A) and (B), 0.5 mm; (C) and (D), 0.25 mm.
(E and F) Toluidine blue–stained sections (1 mm) from the PND43 sciatic nerve are shown. (E), 1/1; (F), 2/2. Bar, 25 mm.
Table 1. Morphometric Analysis of Myelination in PND 24 2/2 Mice
Nerve fibers Parameter 1/1 2/2 p
Optic Axon diameter 1.19 6 0.37 1.17 6 0.39 NS
Fiber diameter 1.42 6 0.39 1.39 6 0.42 NS
Myelin thickness 0.11 6 0.02 0.11 6 0.02 NS
g 0.84 6 0.04 0.84 6 0.03 NS
Dorsal white matter Axon diameter 1.26 6 0.38 1.28 6 0.40 NS
Fiber diameter 1.52 6 0.46 1.51 6 0.44 NS
Myelin thickness 0.13 6 0.05 0.12 6 0.04 ,0.05
g 0.81 6 0.03 0.84 6 0.05 ,0.005
Ventral white matter Axon diameter 1.98 6 1.39 2.01 6 1.50 NS
Fiber diameter 2.36 6 1.39 2.26 6 1.57 NS
Myelin thickness 0.19 6 0.10 0.13 6 0.05 ,0.00001
g 0.82 6 0.05 0.86 6 0.05 ,0.00001
Sciatic Axon diameter 4.01 6 1.18 4.02 6 1.03 NS
Fiber diameter 5.43 6 1.56 5.49 6 1.28 NS
Myelin thickness 0.71 6 0.22 0.73 6 0.17 NS
g 0.74 6 0.04 0.73 6 0.04 NS
A total of 150 fibers from the indicated nerves of two animals for each genotype was analyzed morphometrically. Mean values are shown for
the indicated parameters. Units for diameter and thickness measurements are in micrometers. The g value corresponds to the ratio of axonal
diameter to fiber diameter and reflects the extent to which myelin thickness is affected by axon diameter. This value has been found to vary
between 0.6 and 0.8 depending on the type of nerve fiber and age of the animal (Little and Heath, 1994). Statistical analysis consisted of
single factor ANOVA. NS indicates that the data from the control and mutant animals were not significantly different.
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the depolarizing afterpotential was reduced inamplitude
and duration when compared to 1/1 control (Figure 5B;
Table 2). Furthermore, the reduction in amplitude of the
compound action potential associated with increase in
measurement temperature to 378C from 258C was pro-
portionally greater in 2/2 spinal cord (Table 2). Finally,
superfusion with 100 mM 4-aminopyridine (4-AP), a
blocker of fast K1 channels, had no effect on the ampli-
tude of the compound action potential of 1/1 spinal
cord and registered a small increase of depolarizing
afterpotential amplitude (Figure 5C). In contrast, su-
perfusion of the 2/2 spinal cord with 100 mM 4-AP
resulted in a reversible increase in amplitude and dura-
tion of the compound action potential (Figure 5D).
Myelin in Cgt2/2 Mice Shows
Regional Instability
At PND 24, little pathology was notable in 2/2 animals
except for a small amount of vacuolation in the ventral
columns of the spinal cord (Figure 6B). Electron micro-
graphs revealed that z10% of the axonal processes in
this region exhibited mild myelin splitting, comparedFigure 4. Analysis of Myelin Lipids
with z2% in control animals (data not shown). SplittingMyelin was purified from brain of Cgt 1/1 and 2/2 mice. Total lipid
fractions from isolated myelin were applied to an untreated HPTLC was restricted to the sheaths of the large caliber axons.
60 plate at 285 mg dry myelin equivalent (estimated 200 mg total In contrast, PND 43 2/2 animals exhibited extensive
lipid at 70%) and chromatographed in chloroform-methanol-water vacuolation in the ventral columns of the spinal white
(70:30:4). Bands were visualized by copper acetate spray and heat-
matter (Figure 6D). At PND 43 splitting was observed ining. Abbreviations: NFA, normal fatty acid; HFA, a-hydroxy-fatty
the myelin sheath of virtually every large caliber process,acid;glc-cer, glucocerebroside; Chol, cholesterol; PE, ethanolamine
and the extent of splitting was dramatically more severephospholipids; PC, choline phospholipids; SPM, sphingomyelin.
than at PND 24 (Figures 6E and 6F). Some vacuolation
Figure 5. Action Potential Conduction in Cgt2/2 Mice
(A) Diagram of the recording apparatus. The hemisected spinal cord was placed in a Plexiglas chamber, with the central channel (3.5 mm
wide) superfused by flowing, oxygenated Krebs’ solution and the two ends isolated by sucrose gaps in chambers containing isotonic (120
mM) potassium chloride solution. Silver/silver chloride electrodes were used to record the potential across one gap and to stimulate the spinal
cord across the other.
(B) The compound action potential recorded in the Cgt 2/2 and 1/1 spinal cord are shown.
(C and D) The effect of superfusion with 100 mM 4-aminopyridine (4-AP) on the compound potential in 1/1 (C) and 2/2 (D) spinal cord is
shown.
The calibration pulse preceding the stimuli in all traces was 1 mV and 1 ms.
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Table 2. Characteristics of Compound Action Potentials in was observed in the PND 43 optic nerve, but not to the
Cgt2/2 Spinal Cord same extent as in the spinal cord (data not shown).
Electron microscopy of the 2/2 spinal cord showed1/1 2/2
myelin lamellae splitting along the intraperiod line (Fig-Amplitude at 378C (mV) 9.5 6 1.5 2.5 6 0.6
ures 6E and 6F) and occasionally by dilated periaxonal
Amplitude Reduction (%) after 37.4 6 3.9 61.8 6 5.8 space (data not shown). No pathology was observed in
Temperature Increase from
the dorsal white matter (data not shown) or sciatic258C to 378C
nerves of PND 43 2/2 animals (Figure 3F).
Peak latency (ms) 0.18 6 0.03 0.55 6 0.04
Response to 4-AP 4.0 6 1.1 25 6 4.7 Discussion
(% amplitude increase)
Absolute refractory period (ms) 0.45 6 0.04 1.07 6 0.10 We have initiated studies directed at determining the
function of GalC and sulfatide in myelin formation andCompound action potentials were recorded from spinal cords iso-
maintenance. To this end, we used gene targeting tolated from 1/1 and 2/2 animals (n 5 4 per group). Mean values
with (SEM) are reported. Variables were significantly different be- generate mice deficient in CGT, the enzyme responsible
tween wild type and mutant (p , 0.05, ANOVA). for GalC biosynthesis (Morell and Radin, 1969). Mice
lacking CGT cannot synthesize GalC or sulfatide (Figure
2) but are able to form compact myelin (Figure 3). That
Figure 6. Ultrastructural Analysis of Spinal Cord in PND 24 and 43 Cgt2/2 Mice
(A–D) Toluidine blue–stained sections (1 mm) from the ventral column of the spinal cord from PND 24 (A and B) and PND 43 (C and D) animals
are shown. (A) and (C), 1/1; (B) and (D), 2/2 . Bar, 25 mm.
(E and F) Electron microscopy of selected regions of the ventral column of the spinal cord from PND 43 2/2 animals are shown. The arrows
indicate regions of myelin splitting. Bar, 0.5 mm.
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CGT-deficient mice are able to form myelin was surpris- afterpotential, since this potential appears to be based
ing. Given Bansal and Pfeiffer’s (1989) observation that normally on the slow passive discharge of the internodal
oligodendrocyte differentiation was reversibly inhibited axolemma (Barrett and Barrett, 1982; Blight, 1985; David
by antibodies to GalC, we anticipated that oligodendro- et al., 1995). The sensitivity of the 2/2 action potential
cyte development would be disrupted in these mice. to the K1 channel blocker 4-AP reflects this increased
Clearly, our findings show that oligodendrocyte differen- activation and also indicates that there are alterations
tiation is not grossly affected by the absence of GalC in the myelin sheath that allow exposure of the channels
or sulfatide. Other studies have also suggested that to the drug.
GalC may function as a signaling molecule by opening While it is clear that the electrophysiological proper-
calcium channels in cultured oligodendrocytes (Dyer ties of the myelin sheath are altered and that the mutant
and Benjamins, 1988, 1989, 1990, 1991). While these in animals are clinically severely affected, these changes
vitro studies convincingly demonstrated that anti-GalC might be attributable to structurally abnormal myelin, to
antibodies can trigger influx of calcium and subsequent hypomyelination, or to compositional changes of the
cytoskeletal rearrangement, our data cast doubt on the sheath. Nevertheless, the microscopic and morphomet-
in vivo relevancy of these findings. If GalC is a signaling ric analyses clearly show well-formed and relatively nor-
molecule, it cannot be vital to oligodendrocyte develop- mal amounts of myelin in the 2/2 mice. While the thick-
ment and differentiation, and as a consequence, to my- ness of myelin in the ventral white matter of 2/2 animals
elination. is reduced to 70% of controls, it seems unlikely that such
One explanation for the ability of CGT-deficient mice minor regionalhypomyelination could be responsible for
to form myelin stems from our finding that glucocerebro- the profound clinical and electrophysiological effects
side (GlcC) is present in myelin of these animals (Figure observed. Indeed, studies of the shiverer mouse—which
4), although only at z20% of the normal total galactoli- is characterized by extensive hypomyelination resulting
pids. The relative abundance of HFA-GlcC is unusual from disruption of MBP expression—have shown that
given that the amount of GlcC in the normal mouse the defect can be corrected with myelin levels at <50%
brain is minuscule, owing to its utilization in ganglioside of normal (Readhead et al., 1987). Moreover, thedetailed
biosynthesis (Hammarstro¨m, 1971). The a-hydroxy cera- morphometric analysis of optic nerves of animals that
mide normally destined for HFA-GalC is most likely used express graded levels of myelin demonstrate that myelin
for the synthesis of HFA-GlcC and HFA-sphingomyelin
thickness at <50% of control are sufficient for a normal
in the CGT-deficient animals. Biochemically, GlcC ex-
phenotype (Shine et al., 1992). Given these quantitative
hibits properties similar to GalC. In vitro, GalC and GlcC
observations, it seems unlikely that the slight and re-
form highly stable lamellar phases that require high tem-
gional hypomyelination observed in the Cgt2/2 animalsperature (808C–908C) to disrupt (Koynova and Caffrey,
can account for the severe clinical and electrophysiolog-
1995). This thermodynamic similarity would suggest that
ical defects. Rather, it seems more likely that the compo-GlcC may be able tosubstitute for thestructural function
sitional change in myelin lipids in the 2/2 animals isattributed to GalC (Curalto, 1987). In contrast, biochemi-
responsible for the physiological defects. While the sub-cal properties of HFA-sphingomyelin are unclear since
stitution of GlcC may allow for myelination to occur,this is the first report of this lipid.
the absence of GalC likely has profound effects on theDespite the presence of compact myelin in the mutant
physiological properties of the sheath. Furthermore, theanimals, the electrophysiological analysis showed that
absence of sulfatide may also have detrimental conse-nerve function in the spinal cord is disrupted (Figure 5;
quences on the insulative properties of myelin.Table 2). The characteristics of compound action poten-
In addition to the compositional changes in myelin,tials recorded from 2/2 mice are consistent with a de-
myelin splitting likely contributes to the clinical pheno-fect in the insulative capacity of myelin. One contributing
type of the older CGT2/2 animals. This pathology exhib-factor to such a defect would be reduction in the radial
ited a notable progression with very little myelin splittingimpedance (decrease in resistance and/or increase in
in the spinal cord at PND 24 (Figure 5B) and extensivecapacitance) of the myelin sheath. Such a reduction
splitting in the ventral columns of the spinal cord of PNDwould increase leakage of action current along the in-
43 animals (Figure 5D). Indeed the localization of theternode, reduce the safety factor for conduction, and
splitting to the ventral columns is striking and may ac-decrease conduction velocity (Blight, 1985). In addition,
count for the profound hindlimb paralysis typical of olderimpedance alteration would likely lead to a conduction
animals, since many of the large caliber axons in theblock in a proportion of nerve fibers, further reducing
ventral white matter are likely motor neurons. Further-the amplitude of the compound action potential. This
more the striking localization of this pathology to theeffect would be amplified at higher temperatures be-
ventral white matter raises interesting issues regardingcause of the faster kinetics of ion channels (Franken-
the nature of myelin within different regions of the CNS.haeuser and Moore, 1963), as is seen in the 2/2 spinal
Similar myelin instability has been observed in aspar-cord (Table 2).
toacylase deficiency (Canavan disease) in humans (Ada-An additional effect of increased depolarization in the
chi et al., 1972; Beaudet, 1995) and varieties of toxicinternodal axolemma during the action potential would
demyelination resulting from exposure to triethyltin,be the activation of the fast voltage-dependent K1 chan-
hexachlorophene, and cuprizone (Aleu et al., 1963; Su-nels located in this membrane (Black et al., 1990; Wax-
zuki and Kikkawa, 1969; Towfighi et al., 1974; Towfighi,man and Ritchie, 1993). These channels are occluded
1980; Watanabe, 1980). In these instances, myelin splitsby the myelin sheath and ordinarily do not participate
along the intraperiod line possibly as a result of intersti-in the conduction process. Their activation would re-
duce the amplitude and duration of the depolarizing tial edema (Aleu et al., 1963; Adachi et al., 1972; Towfighi
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et al., 1974; Towfighi, 1980; Watanabe, 1980). While our dramatically altered electrophysiological properties ob-
served in these mice indicate an intrinsic role for thesedata do not rule out interstitial edema as a cause of
splitting, the absence of GalC and sulfatide from the lipids in the insulative properties of myelin. Furthermore,
the observed myelin instability clearly implicates GalCexternal leaflet of the plasma membrane must also be
a contributing factor. While GlcC is present, it may be and sulfatide in stabilizing the ultrastructure of the my-
elin sheath. The availability of the CGT-deficient animalsinsufficiently adhesive or may not be sufficiently abun-
dant to maintain the integrity of the sheath. Furthermore, should allow for the further analysis of these and other
important functions of GalC and sulfatide.the absence of the highly charged sulfate moieties con-
tributed by sulfatide may further compromise the adhe-
sive properties of the external leaf of the myelin mem- Experimental Procedures
brane. Nevertheless, the absence of pathology in the
Construction of Cgt Targeting Vectordorsal region of the spinal cord and in the sciatic nerve
The genomic organization of the mouse Cgt gene has been de-suggests a heterogeneity in the tolerance of galactolipid
scribed (Coetzee et al., 1996). Exon 2 was chosen as a target for
eliminationfrom myelinating glia in theseanimals. Future disruption since it codes for the N-terminal half of the CGT enzyme,
studies will be directed at clarifying the mechanism of and because a KpnI site resides 219 nt downstream of the ATG
myelin splitting in 2/2 mice. which would facilitate construction of the targeting vector. A 14.5
kb l genomic clone carrying exon 2 and flanking intronic sequencesIn addition to providing clues to the function of GalC
was subcloned into the SalI site of plasmid pBSSK(1) (pCGTE2)and sulfatide in myelin formation and maintenance,
(Stratagene). Subsequently, a 3.5 kb KpnI fragment (E2KK3.5), con-these studies have resolved two lingering questions re-
taining 3.3 kb of intron I and the first 0.2 kb of exon 2, and a 7.0 kb
garding the biosynthesis of GalC and sulfatide. First, KpnI/SalI fragment (E2KS7) harboring the remainder of exon 2 and
our findings clearly show that only one enzyme exists intron 2 were subcloned from pCGTE2 into plasmid pBSSK(1). The
that catalyzes the synthesis of both NFA- and HFA-GalC parental plasmid for the targeting construct was plasmid pPNT,
which carries pGK-neo-poly(A), herpes simplex virus thymidine ki-(Figure 3). Our findings are consistent with and further
nase, and multiple cloning sites flanking the neo cassette (Tybule-extend a recent study demonstrating that CGT is capa-
wicz et al., 1991). The targeting vector, pPNTCGT, was generatedble of catalyzing the synthesis of both NFA- and HFA-
in a two-step cloning process. First, fragment E2KS7 was digested
GalC in vitro (Schaeren-Wiemers et al., 1995). This study with KpnI, blunt-ended with T4 DNA polymerase, followed by NotI
eliminated the need to postulate a second enzyme to digestion. This fragment was subcloned into the NotI and blunted
account for the known acceptor specificity, but did not XhoI sites upstream of the neo cassette. Subsequently, fragment
E2KK3.5 was subcloned into the KpnI site downstream of the neoexclude the possibility for a second enzyme. Our results
cassette. Orientation was determined by PCR and diagnostic re-clearly exclude the existence of another enzyme. Sec-
striction digestion.ond, our findings confirmed the generally accepted no-
tion that GalC is the exclusive precursor for synthesis
Generation of Cgt2/2 Mice
of sulfatide. NotI-digested pPNTCGT was electroporated into BK4 ES cells, a
While abundantly expressed in myelinating glia, GalC subclone of E14TG2a cells. Neo-resistant clones were isolated using
and sulfatide have also been identified in other cell G418 and standard ES culture methods. Fifty-two neo resistant
clones were screened for the correct recombination event by South-types. In neuronal tissue, these lipids are present in
ern blot hybridization using probe A (Figure 1A). Fourteen positiveaxolemma (De Vries et al., 1972), and CGT expression
clones were identified and one (#33) injected into C57Bl/6J blasto-has been identified in a subset of motor neurons
cysts. Male chimeric mice were bred with C57Bl/6 females, and
(Schaeren-Wiemers et al., 1995). Other studies have agouti offspring screened for transmission of the disrupted allele by
shown that GalC is expressed in peripheral tissues in- Southern blot hybridization using probe B (Figure 1A). Homozygotes
cluding kidney (Costantino-Ceccarini and Morell, 1973) were generated by interbreeding of heterozygote F1 mice. For
Southern blot analysis, 5–10 mg of tail or ES DNA was digested withand colonic epithelia, where it may serve as an alternate
BamHI, separated by agarose gel electrophoresis, transferred toreceptor for HIV in the absence of CD4 expression (Har-
Zeta-Probe (Bio-Rad) using 0.4 N NaOH. Probes were labeled byouse et al., 1991; Yahi et al., 1992; Long et al., 1994).
PCR (Jansen and Ledley, 1989), and hybridization and washes per-
Furthermore, sulfatide is expressed in islets of Langer- formed as previously described (Coetzee et al., 1996).
hans and kidney glomeruli—tissues that are affected by
diabetic disease, possibly as suggested by Buschard RNA Analysis
et al. (1994) as a result of anti-sulfatide antibodies. While Total RNA was prepared from PND 24 brains using the guanidinium
thiocyanate method of Chirgwin et al. (1979). Northern blots werethe functions of GalC and sulfatide in these settings
prepared as described by Popko et al. (1987). Probes for CGTremain unclear, the availability of CGT-deficient mice
(Coetzee et al., 1996), neo (Tybulewicz et al., 1991), MAG (Sutcliffeshould provide a means to better explore this issue.
et al., 1983), MBP (Roach et al., 1983), and PLP (Milner et al., 1985),Together, the data presented provide the first
were prepared by PCR as described above. Hybridization and
glimpses into the function of GalC and sulfatide in myelin washes were performed as previously described (Popko et al., 1987).
formation, function, and maintenance. Indeed, the re- A pair of oligonucleotides for 18S ribosomal RNA were end-labeled
sults of our studies show that the CGT-deficient mice with digoxigenin and used to evaluate relative levels of total RNA
present in each lane. Preparation of the oligonucleotide probe, hy-are distinctive from the naturally occurring and experi-
bridization, and wash conditions followed the instructions of thementally induced myelin mutants that are typified by
manufacturer (Boehringer-Mannheim).extensive hypomyelination or dysmyelination (Campag-
noni and Macklin, 1988; Giese et al., 1992; Boison and
Lipid Analysis
Stoffel, 1994; Li et al., 1994; Montag et al., 1994; Adlkofer Tissues were weighed and extracted with 20 volumes of chloroform-
et al., 1995; Lunn et al., 1995). Our results clearly demon- methanol (2:1, v/v) (Folch-Pi et al., 1957). Insoluble materials were
strate ultrastructurally normal myelin can be formed in removed by centrifugation. The extract was partitioned with addition
of 0.2 volume of water, the upper phase discarded and the lowerthe absence of GalC and sulfatide. Nevertheless, the
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phase washed once with the pure solvent upper phase (chloroform- Krebs’ solution at room temperature for at least 1 hr, then mounted
in a recording chamber, as illustrated in Figure 7A. The temperaturemethanol-water, 4:48:47, v/v/v) and dried under a stream of nitrogen.
The dried lipid was dissolved in chloroform-methanol (2:1, v/v) at 1 of the chamber was raised to 378C, and a series of recordings
made of the response to stimulation over a range of intensitiesml/100 mg tissue. The total lipid fractions were first chromato-
graphed on thin-layer plate (HPTLC 60, Merck) at 20 ml (2 mg wet and interpulse intervals. The data were digitized and recorded on
videotape for subsequent analysis using customized Labview soft-weight tissue) per sample in the solvent system of chloroform-meth-
anol-water (70:30:4) and lipid bands visualized with copper acetate ware on a Power Macintosh computer. 4-aminopyridine (Regis
Technologies, Morton Grove, IL) was dissolved in the Krebs’ solu-spray and heating (3% copper acetate in 15% phosphoric acid).
Then the lipids were subjected to the mercuric chloride-saponifica- tion, at pH 7.3.
tionprocedure (Abramson et al., 1965) in order to degrade essentially
all glycerophospholipids. After solvent partitioning, the lower lipid Acknowledgments
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